Researchers have created panels for ovarian hyperstimulation syndrome and to detect mutations in BCR-ABL1 gene fusions.
Diagnostic sequencing will be done on the Illumina HiSeq X Ten, the HiSeq 2500, and the NextSeq 500 in HudsonAlpha's CLIA-certified Genomics Services Laboratory.
The privately-held German firm also plans to offer genetic tumor profiling and noninvasive prenatal testing.
The four-year project aims to sequence about 800 kids and their parents to get a clearer idea of the genetic underpinnings of birth defects with unknown causes.
The retrospective study, by researchers at Children's Mercy Kansas City, suggests the STAT-seq test has clinical utility in some patients.
In Science this week: factors influencing retrotransposon integration sites, and more.
A bioethicist argues for the responsible use of germline gene editing.
Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.
Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.